▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3760 by analyst upside · 2026-11-13
LH
Labcorp Holdings Inc.
Healthcare · Market Cap $30B · P/E 30.5x
ANALYST PRICE TARGET
+4.8%
implied upside to consensus target
Current Price $372.32
Consensus Target $390.06
Bull Target $420.0
Bear Target $347.0
Analysts Covering 16
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
10
Hold
4
Sell
0
52-Week Low $245.0
52-Week High $375.1
YTD Return +49.0%
FUNDAMENTALS
Market Cap $30B
P/E Ratio (TTM) 30.5x
Forward P/E 19.0x
EPS (TTM) $12.20
PEG Ratio 1.65
Dividend Yield 0.77%
Revenue (TTM) $14.6B
Profit Margin 6.9%
52-WEEK RANGE
52-Week Low $245.0
52-Week High $375.1
Current Price $372.32
Bear Target $347.0
Bull Target $420.0
● Now $372.32 ● Target $390.06
TRADING DATA
Avg Volume 739K
YTD Return +49.0%
Analyst Count 16
Consensus Buy
Upside to Target +4.8%
Last Updated 2026-11-13

ANALYST SUMMARY

Labcorp Holdings Inc. (LH) is currently trading at $372.32 with a Wall Street consensus price target of $390.06, implying potential upside of 4.8% over the next 12 months. 16 analysts currently cover LH, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $420.0, while the most cautious has a target of $347.0.

LH operates in the Healthcare sector with a market capitalisation of $30B. The stock is up 49.0% year-to-date and is currently trading near the upper end of its 52-week range of $245.0 – $375.1.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for LH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Buy → Buy 2026-10-29 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-10-29 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-10-29 Building track record
Baird - Reiterated
Outperform → Outperform 2026-10-29 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-09-21 Building track record
UBS - Reiterated
Buy → Buy 2026-09-11 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-09-11 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2026-08-04 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
22/30
Consensus clarity
26/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →